Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04317482 · ClinicalTrials.gov registry record · NA

The Human Stress Response in a Simulated ED Setting

A NA study of Substance Use Disorders and Methamphetamine-dependence, sponsored by University of Arkansas.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04317482: Active NA study of Substance Use Disorders and Methamphetamine-dependence, sponsored by University of Arkansas.

NCT04317482 is a NA study of Substance Use Disorders and Methamphetamine-dependence that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 30 participants, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04317482, a NA study of Substance Use Disorders and Methamphetamine-dependence, is active but no longer recruiting, sponsored by University of Arkansas.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Stress is important for health. As emergency departments (EDs) are often stressful places, a better understanding of the human stress response is important for understanding how and why patients respond as they do when they come to the ED. Since the investigators cannot take up space in the ED for research, the investigators will instead recruit 20 methamphetamine-using participants who are not currently in treatment and 10 healthy adult matched participants to a simulated ED room in the University of Arkansas for Medical Sciences (UAMS) Simulation Center. The investigators will have participants perform a stressor task involving public speaking and a simple arithmetic task. The investigators will see if this experiment can be made to be like being in an actual ED by varying what participants speak about in the task. By doing this, the investigators hope to find out several important things: 1) Is a stressor task feasible and acceptable to participants? 2) What does the stress response -- as measured by cortisol and alpha-amylase -- look like in these participants? 3) Does varying what participants talk about make the experiment seem more like an actual ED? 4) Do participants under stress show even mild symptoms of agitation as measured by clinical scales? If so, how often?

Primary Outcome

Measure feasibility and acceptability in the following ways: participant recruitment; the number of participants completing the experiment; and the acceptability ratings of the task after completion. The 9-point acceptability responses will be analyzed by calculating the mean and 95% confidence intervals for each question, then calculating a chi-square goodness of fit test across the 3 ranges of the scores. Answers to open-ended questions about participant experiences will be coded using conven

Interventions

  • BEHAVIORAL Standard social stress task
  • BEHAVIORAL Stressful experience in the ED

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-08-26
Est. Completion 2026-12
Phase NA
University of Arkansas

318 total trials

What the registry record for NCT04317482 still lists

NCT04317482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (94% lower).

The record links to 5 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Standard social stress task is the first listed.

NCT04317482 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT04317482 about?

NCT04317482 is a clinical study titled "The Human Stress Response in a Simulated ED Setting". Stress is important for health. As emergency departments (EDs) are often stressful places, a better understanding of the human stress response is important for understanding how and why patients respond as they do when they come to the ED. Since the investigators cannot take up space in the ED for r...

What is the current status of trial NCT04317482?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2020-08-26. Estimated completion is 2026-12.

What conditions does trial NCT04317482 study?

This clinical trial studies the following conditions: Substance Use Disorders, Methamphetamine-dependence, Stress, Emotional, Stress Reaction, Stress Physiology.

What interventions are being tested in trial NCT04317482?

The interventions under investigation include: Standard social stress task (BEHAVIORAL), Stressful experience in the ED (BEHAVIORAL).

Who is sponsoring clinical trial NCT04317482?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04317482 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04317482's enrollment target sits among peer trials

30 77th of 93 higher than 14 of 93 other Substance Use Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04317482, the US trial registry maintained by the National Library of Medicine. NCT04317482 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.